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Abstract: Ionic platinum(II) complexes [PtCl(PPh3)(L˄L)][BF4] {L˄L = 2,2'-bipyridyl (1) 1,10-
phenanthroline (2)} and [PtCl(PPh3)(L)2][BF4] {L = pyridine (3), dimethyl sulfoxide (4)} were 
synthesized by dehalogenation of cis-[PtCl2(PPh3)(NCMe)], followed by reaction with the suitable 
ligand. Chelating nitrogen ligands L˄L afforded single products, which were structurally 
characterized. In the other cases mixtures of geometric (L = pyridine) and/or coordination (L = 
dimethyl sulfoxide) isomers were observed in solution. In these cases the structures of the less 
soluble isomers were obtained via single crystal X-ray diffraction. All the complexes were tested in 
vitro for their antiproliferative activity on three human tumor cell lines: MSTO-211H, HeLa and 
HepG2. 
Keywords: platinum(II); triphenylphosphine; ionic complexes; chelating ligands; antiproliferative 
activity. 
1. Introduction 
Following the early discover of cisplatinum anticancer properties [1], hundreds of new platinum(II) 
complexes have been synthesized and tested in vitro for their antiproliferative activity. Among 
them, ionic, monofunctional complexes were originally disregarded as inactive [2], but have 
recently gained renewed interest as non-conventional anticancer agents displaying ranges of 
applicability and mechanisms of action other than classical agents [3]. The most studied 
  
monofunctional ionic derivatives include [PtClL2L'][X] complexes, where “L2” represents a 
bidentate amine or two monodentate amine residues and L' is a N-heterocycle [3c,e-f,m], a 
sulfoxide [3i,k-l] or a thiourea derivative [3g], while fewer examples are described where 
monofunctional complexes contain P-coordinated ligands [4].  
In the context of our studies concerning platinum (II) complexes containing triphenylphosphine [5], 
we have prepared four new ionic complexes characterized, besides PPh3, by a chloride and, on the 
other two coordination sites, by a chelating N,N- coordinated ligand (1, 2, Figure 1) or two non-
chelating ligands (3, 4, Figure 1). We report here the synthesis, the characterization and the 
antiproliferative activity of 1-4 against MSTO-211H (human biphasic mesothelioma), HeLa (human 
cervix adenocarcinoma) and HepG2 (human hepatocellular carcinoma) cell lines. 
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Figure 1. Structure of monocationic complexes 1-4. Counterion was [BF4]- for all complexes. 
 
 
 
 
  
2. Experimental 
2.1. Materials and general methods 
 All manipulations were performed under a dinitrogen atmosphere, if not otherwise stated. 
Solvents and liquid reagents were dried according to reported procedures [6]. 1H-, 13C-, 31P-and 
195Pt-NMR spectra were recorded with a Bruker ‘‘Avance DRX400’’ spectrometer, in CD3CN 
solution if not otherwise stated. Chemical shifts were measured in ppm (δ) from TMS by residual 
solvent peaks for 1H- and 13C-, from aqueous (D2O) H3PO4 (85%) for 31P- and from aqueous (D2O) 
hexachloroplatinic acid for 195Pt-NMR. A sealed capillary containing C6D6 was introduced in the 
NMR tube to lock the spectrometer to the deuterium signal when non-deuterated solvents were 
used. FTIR spectra in solid phase were recorded with a Perkin–Elmer ‘‘Spectrum One’’ 
spectrometer, equipped with an ATR accessory. Elemental analyses (C, H, N) were performed at 
Dipartimento di Scienze e Tecnologie Chimiche, Università di Udine. Cis-[PtCl2(PPh3)(NCMe)] 
was prepared according to a reported procedure [5f]. In the text the following abbreviations were 
used: 2,2'-bipyridyl (bipy); 1,10-phenanthroline (phen); pyridine (py).  
 
2.2. General procedure for the synthesis of ionic complexes 1-3. 
 A portion of cis-[PtCl2(PPh3)(NCMe)] (~ 0.5 mmol) was warmed (40 °C) and stirred in a 
mixture of MeCN and MeNO2 (1/1 v/v) up to complete dissolution of the reagent. Solid AgBF4 
([Ag]/[Pt] molar ratio = 1.2) was added under stirring and the flask was shielded from light. A 
colorless solid formed immediately and the suspension was stirred at room temperature for 1 h. A 
sample of the supernatant colorless solution was analyzed (31P-NMR: 0.30, 1JP-Pt = 3748 Hz). The 
suspension was filtered on a short package of dry celite and the resulting colorless solution was 
treated with the suitable ligand ([L˄L]/[Pt] molar ratio = 1.0 for the chelating ligands and [py]/[Pt] 
molar ratio = 2.0 for py). The solution was monitored until complete conversion was obtained (31P-
NMR). Later on, it was concentrated in vacuo and Et2O was added. Solid products were filtered, 
washed with two portions of Et2O and dried in vacuo (10-2 mmHg). For each complex the isolated 
product % yield, the elemental analysis and the spectroscopic (IR and NMR) characterization are 
reported below. 
2.2.1 Cis-[PtCl(PPh3)(bipy)][BF4], 1. 
 50 % yield. Anal. Calcd. for C28H23BClF4N2PPt: C 45.7, H 3.2, N 3.8 %. Found: C 45.4, H 
2.8, N 3.9 %. IR (ATR, cm-1): 3086, 1606, 1451, 1432, 1315, 1276, 1243, 1174, 1098, 1054, 1046, 
1033, 1024, 767, 752, 746; 1H-NMR: 9.58 (m, 1H, 3JH-Pt = 36.0 Hz, Habipy, Fig. 1), 8.45 (m, 4H, 
  
Hbipy),7.97-7.87 (m, 8H, 2Hbipy + 6 Harom phosphine), 7.65 (m, 3H, Harom phosphine), 7.55 (m, 6H, 
Harom phosphine), 7.07 (m, 1H, Hbbipy, Fig. 1); 13C-NMR: 157.9, 156.1, 152.3, 147.9, 142.4, 141.4, 
135.0 (JC-P = 10.9 Hz), 132.4, 129.0 (JC-P = 11.5 Hz), 129.9, 127.7, 126.8 (1JC-P = 64.7 Hz),124.6, 
123.9; 31P-NMR: 11.32 (1JP-Pt = 3677 Hz); 195Pt-NMR: -3541 (1JPt-P = 3677 Hz). A sample of solid 
was dissolved in MeNO2 and crystallized by slow diffusion of diethyl ether vapors. Single crystals 
were selected for X-ray diffraction analysis. 
2.2.2. Cis-[PtCl(PPh3)(phen)][BF4], 2. 
 54 % yield. Anal. Calcd. for C30H23BClF4N2PPt: C 47.4, H 3.1, N 3.7 %. Found: C 47.2, H 
2.7, N 3.8 %. IR (ATR, cm-1): 3104, 3064, 1588, 1519, 1481, 1438, 1260, 1096, 1047, 1035, 845, 
747; 1H-NMR: 9.84 (m, 1H, Haphen, Fig. 1), 8.99 (m, 1H, Hphen), 8.80 (m, 1H, Hphen), 8.26 (m, 4H, 
Hphen), 7.93 (m, 6H, Harom phosphine), 7.66 (m, 3H, Harom phosphine), 7.55 (m, 6H, Harom 
phosphine), 7.41 (m, 1H, Hbphen, Fig. 1); 13C-NMR: 158.1, 152.5, 148.8, 146.5, 141.3 (2C), 140.9 
(2C), 135.2 (JC-P = 10.8 Hz), 132.4 (JC-P = 2.5 Hz), 129.0 (JC-P = 11.7 Hz), 128.2, 128.0, 126.8 (1JC-P 
= 64.7 Hz), 126.1, 126.0; 31P-NMR: 11.09 (1JP-Pt = 3690 Hz); 195Pt-NMR: -3587 (1JPt-P = 3690 Hz). 
A sample of solid was dissolved in MeNO2 and crystallized by slow diffusion of diethyl ether 
vapors. Single crystals were selected for X-ray diffraction analysis.  
2.2.3. Trans-[PtCl(PPh3)(Py)2][BF4], 3. 
 60 % yield. Anal. Calcd. for C28H25BClF4N2PPt: C 45.6, H 3.4, N 3.8 %. Found: C 45.1, H 
3.4, N 3.9%. IR (ATR, cm-1): 3109, 3081, 3041, 1611, 1484, 1459, 1435, 1315, 1287, 1212, 1162, 
1049, 1033, 996, 963, 881, 832, 768, 751, 710, 690; 1H-NMR: 8.51 (m, 4H, 3JH-Pt = 38.4 Hz, CHN), 
7.75 (m, 2H, CHCHCHN), 7.64 (m, 6H, Harom phosphine), 7.55 (m, 3H, Harom phosphine), 7.42 (m, 
6H, Harom phosphine), 7.20 (m, 4H, CHCHCHN); 13C-NMR: 152.8, 139.8, 133.7 (JC-P = 10.6 Hz), 
132.1, 129.3 (JC-P = 11.5 Hz), 126.8, 124.5 (1JC-P = 63.2 Hz); 31P-NMR: 5.20 (1JP-Pt = 3824 Hz); 
195Pt-NMR: -3242 (1JPt-P = 3824 Hz). Single crystals were selected for X-ray diffraction analysis, 
which confirmed trans geometry. 
2.3. Synthesis of [PtCl(PPh3)(SOMe2)(OSMe2)][BF4], 4. 
A sample (0.3035 g) of cis-[PtCl2(PPh3)(NCMe)] (0.533 mmol) was warmed (40 °C) and stirred in 
a mixture of DMSO and MeNO2 (1/1 v/v) up to complete dissolution of the reagent. 31P-NMR 
analysis on a sample of the solution showed the formation of cis-[PtCl2(PPh3)(DMSO)] (17.56, 1JP-
Pt = 3770 Hz) [5c]. Solid AgBF4 ([Ag]/[Pt] molar ratio = 1.2) was added under stirring and the flask 
was shielded from light. A colorless solid formed immediately and the suspension was stirred at 
  
room temperature for 1 h. 31P-NMR analysis on a sample of the supernatant liquid showed: 21.65 
(65 %, 1JP-Pt = 3906 Hz), 9.16 (35 %, 1JP-Pt = 4058 Hz). The mixture was filtered on a short package 
of celite and the filtrate was concentrated up to half volume and treated with dry ethanol. Colorless 
crystals of [SP4-3]-4 formed. A second crop of solid was obtained by precipitation with diethyl 
ether, in overall 34 % yield. Anal. Calcd. for C22H27BClF4S2O2PPt: C 35.9, H 3.7%. Found: C 35.2, 
H 3.2%. IR (ATR, cm-1): 3078, 3019, 2963, 1542, 1483, 1439, 1320, 1170, 1049, 1020, 899, 792, 
760, 693; 1H-NMR (CD3NO2, mixture of [SP4-3]-4/[SP4-2]-4 in 70/30 molar ratio, signals of 
aliphatic hydrogens): [SP4-3]-4: 3.48 (s, 6H, 3JH-Pt = 25.6 Hz, PtS(O)(CH3)2), 2.47 (s, 6H, 
PtOS(CH3)2); [SP4-2]-4: 3.20 (s, 6H, 3JH-Pt = 18.0 Hz, PtS(O)(CH3)2), 2.98 (bs, 6H, PtOS(CH3)2); 
13C-NMR: (CD3NO2): [SP4-3]-4: 136.0 (JC-P = 10.8 Hz), 133.8, 130.2 (JC-P = 11.9 Hz), 127.3 (1JC-P 
= 67.6 Hz), 47.5, 38.2; [SP4-2]-4: 135.9 (JC-P = 10.5 Hz), 133.7, 130.0 (JC-P = 12.0 Hz), 125.3 (1JC-P 
= 65.3 Hz), 44.4, 37.1; 31P-NMR: (CD3NO2): [SP4-3]-4: 19.09 (1JP-Pt = 3883 Hz); [SP4-2]-4: 6.68 
(1JP-Pt = 4045 Hz);195Pt-NMR (CD3NO2): [SP4-3]-4: -3626 (1JPt-P = 3883 Hz); [SP4-2]-4: -3832 (1JP-
Pt = 4045 Hz). Single crystals were selected for X-ray diffraction analysis, which confirmed the 
mode of coordination of DMSO residues and the geometry in [SP4-3]-4. A sample of these crystals 
was dissolved in CD3NO2 and analyzed: 31P-NMR: 19.09 (1JP-Pt = 3883 Hz), 6.68 (1JP-Pt = 4045 Hz). 
2.3. Inhibition growth assay  
HepG2 (human hepatocellular carcinoma cells) and HeLa (human cervix adenocarcinoma cells) 
were grown in Dulbecco’s Modified Eagle’s Medium (Sigma Chemical Co.) and Nutrient Mixture 
F-12 [HAM] (Sigma Chemical Co.), respectively. MSTO-211H (human biphasic mesothelioma 
cells) were grown in RPMI 1640 (Sigma Chemical Co.) supplemented with 2.4 g/L HEPES and 
0.11 g/L pyruvate sodium. 100 U/mL penicillin, 100 µg/mL streptomycin, 0.25 µg/mL 
amphotericin B (Sigma Chemical Co.) and 10% heat-inactivated fetal bovine serum (Invitrogen) 
were added to all media. The cells were cultured at 37°C in a moist atmosphere of 5% carbon 
dioxide in air. Cells (3 x 104) were seeded into each well of a 24-well cell culture plate. After 
incubation for 24 h, 20 µM concentration of the test agents was added to complete medium. The 
cells were then incubated in standard conditions for a further 72 h. Stock solutions of new 
complexes were made in dimethyl sulfoxide at 20 mM concentration and then diluted with complete 
medium in such way that the final amount of solvent did not exceed 0.5%. A trypan blue assay was 
performed to determine cell viability. Cytotoxicity data were expressed as percentage of viability 
with respect to control cultures. 
 
 
2.4. X-ray structure determination 
  
The X-ray diffraction experiments were carried out at room temperature by means of a Bruker 
Smart Breeze CCD diffractometer operating with graphite-monochromated Mo-Kα radiation for 
samples 2, 3 and 4 and a Oxford Xcalibur3 diffractometer operating with Cu-Kα radiation for 
sample 1. The samples were sealed in glass capillaries and their lattice parameters were evaluated as 
a preliminary step to the crystallographic study. The values obtained are reported in Table 1. On the 
basis of those results the intensity data collections were done up to the limits mentioned in the table. 
The intensities were corrected for Lorentz and polarisation effects and for absorption by means of a 
multi-scan method [7] for 2, 3 and 4 and by an analytical method based on the crystal shape [8] for 
1. The structure solutions were obtained by the automatic direct methods contained in SHELX97 
programme [9]. The abnormal anisotropy in the displacement parameters of fluorine atoms 
observed after the first refinement cycles either in 2 or in 3 and in 4 was considered as the result of 
disorder in the BF4− orientation. So the anions of those compounds were refined as distributed in 
two limit positions. For what concerns the structure of compound 4, which contains two 
dimethylsulfoxide ligands bonded in two different ways, the abnormal anisotropy was present also 
in displacement parameters of the chlorine ligand and in some atoms of the O-connected 
dimethylsulfoxide. This feature, together with the presence of residual electron density peaks 
around the same dimethylsulfoxide, suggested us that further disorder was present also in these 
moieties of the cation. So both the chlorine and the O-connected dimethylsulfoxide ligand were 
introduced in this model as distributed in two limit positions. After the introduction of hydrogen 
atoms in calculated positions all the heavy atoms were refined with anisotropic thermal parameters 
till the reliability factors listed in Table 1.  
In addition to the aforementioned software, other control calculations and preparation of publication 
material were performed with the programs contained in the suite WINGX [10]. 
 
Table 1. Crystal data and structure refinements 
 1 2 3 ⋅ 0.5(acetonitryl) 4 
Formula C28H23BClF4N2PPt C30H23BClF4N2PPt C29H26.50BClF4N2.50PPt C22H27BClF4O2PPtS2 
Fw (g⋅mol−1) 735.80 759.82 758.35 735.87 
λ (Å) 1.54184 0.71073 0.71073 0.71073 
Crystal system Monoclinic Monoclinic Monoclinic Monoclinic 
Space group P 21/c P 21/c C 2/c P 21/c 
a (Å) 9.82764(10) 10.4093(4) 29.014(2) 13.0960(3) 
b (Å) 9.66342(10) 28.9096(11) 10.0688(8) 11.3103(4) 
c (Å) 27.8911(3) 9.9297(4) 20.4056(17) 18.7516(5) 
β (°) 90.1149(10) 114.589(2) 99.317(3) 92.068(2) 
V (Å3) 2648.77(5) 2717.15(19) 5882.6(8) 2775.67(14) 
Z 4 4 8 4 
ρcalc (Mg⋅m−3) 1.845 1.857 1.713 1.761 
µ (mm−1) 11.844 5.373 4.964 5.404 
  
θ range (°) 4.499 - 72.370 3.092 - 32.426 2.941 - 35.972 2.174 - 26.948 
Data collected 15009 34268 40943 22193 
Independent reflections 4949 9604 12193 5976 
Rint 0.0419 0.0496 0.0204 0.0480 
Restraints/Parameters 0 / 343 0 / 331 0 / 307 106 / 401 
Goodness-of-fit (GOF) on F2 1.011 0.942 1.020 1.056 
R1; wR2 [I > 2σ (I )] 0.0328; 0.0747 0.0468; 0.0947 0.0386; 0.1141 0.0434; 0.0967 
R1; wR2 [all data] 0.0458; 0.0810 0.0896; 0.1101 0.0653; 0.1331 0.0843; 0.1151 
Res. dens. (e⋅Å−3) 0.992; −1.296 1.362; −0.836 1.804; −3.033 1.594; −0.727 
 
3. Results and discussion 
3.1. Syntheses and characterizations. 
The preparation of complexes 1-4 was carried out starting from cis-[PtCl2(PPh3)(NCMe)] [5f], 
according to the synthetic sequence depicted in Scheme 1. The syntheses were conveniently 
followed by 31P-NMR spectroscopy. 
Dechlorination of the precursor by AgBF4 was efficiently achieved at room temperature, in 
MeNO2/MeCN mixture and afforded cis-[PtCl(PPh3)(NCMe)2][BF4] as single intermediate 
(Scheme 1, A), as shown by the single signal observed in the 31P-NMR spectrum (0.30, 1JP-Pt = 3748 
Hz). This intermediate was not isolated, but cis geometry can be assumed on the basis of the strong 
trans effect exerted by PPh3 ligand. Slow, partial isomerization to trans isomer was observed in 
solution, with the appearance of a new signal (5.04, 1JP-Pt = 3748 Hz) in about 30% amount, after 
24h. Noteworthy, at room temperature, the second chloride is not removed from the platinum 
coordination sphere, even using a slight excess of AgBF4. 
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Scheme 1. Synthesis of 1-4. 
After removal of solid AgCl, the addition of equimolar amounts of chelating ligands 2,2'-bipyridine 
or 1,10-phenanthroline afforded smoothly complexes 1 and 2. Both compounds, as expected for 
  
symmetrical, chelating ligands, showed a single signal with satellites in the  31P-NMR spectrum and 
a single doublet in the 195Pt-NMR spectrum. They were recovered in good isolated yield, after 
concentration of the mixture and addition of diethylether. The elemental analyses, IR (ATR) 
spectroscopy and the 1H- and 13C-NMR characterization in solution were in agreement with the 
proposed structures. It is worth to mention that in the 1H-NMR spectra of complexes 1 and 2 non-
equivalent hydrogen atoms a and b (Figure 1) afforded two well separated signals, that were 
assigned by comparison with analogous triphenylphosphine complexes bearing cis and/or trans N-
heteroaromatic ligands [11]. Both 1 and 2 were crystallized by slow diffusion of diethylether vapors 
into acetonitrile solutions and the structures were determined by X-ray diffraction. 
The treatment of intermediate A with pyridine (2.2 molar equivalents) afforded a mixture of two 
products, as shown by 31P-NMR analysis. The kinetic product cis-3 (4.28, 1JP-Pt = 3568 Hz) was 
initially observed as the main component of the mixture, together with trans-3 (6.46, 1JP-Pt = 3826 
Hz). After 72h, anyway, trans-3 was the main product in solution (80 %) and it was recovered pure 
after precipitation by diethylether. Its stereochemistry was checked by X-ray diffraction on a single 
crystal. Full NMR characterization (1H-, 31P-, 13C- and 195Pt-) of trans-3 was carried out in CD3CN, 
where the complex isomerizes very slowly. As expected, the four equivalent hydrogen atoms 
closest to the coordinated nitrogen atoms of pyridine rings, afforded a single, well separated 1H-
NMR multiplet with satellites (3JH-Pt = 38.4 Hz). 
The addition of dimethylsulfoxide (2.2 molar equivalents) to intermediate A did not cause any 
variation in the solution, showing thus a competition between DMSO and acetonitrile for 
coordination to platinum(II). Even when most of excess MeCN was eliminated, 31P-NMR spectrum 
of the reaction mixture showed signals ascribable to species still containing coordinated acetonitrile. 
In a second experiment, thus, reaction was carried out in MeNO2/DMSO (Scheme 1, preparation of 
4). Dissolution of cis-[PtCl2(PPh3)(NCMe)] in the used solvents caused its complete conversion into 
cis-[PtCl2(PPh3)(SOMe2)] [5c], as shown by the appearance of a single signal in the 31P-NMR 
spectrum (17.56, 1JP-Pt = 3770 Hz). After addition of AgBF4 and elimination of solid AgCl, two 
products were observed in the solution [31P-NMR: 21.65 (65 %, 1JP-Pt = 3906 Hz), 9.16 (35 %, 1JP-Pt 
= 4058 Hz)]. Crystals suitable for X-ray diffraction were obtained upon addition of dry ethanol and 
were identified as [SP4-3]-4, where two DMSO molecules are coordinated to platinum in mutual 
trans position, one by S- and the other by O- atoms. Although sulfoxides generally prefer S-
coordination to platinum [12], examples of O-coordination are described [12,13]. IR (ATR) 
spectroscopic analysis was carried out on a sample of the crystals, where two bands at 1170 and 899 
cm-1 were attributed to S‒O stretching vibrations in S-coordinated and O-coordinated DMSO 
respectively, in agreement with literature data [12,13d]. A freshly prepared solution of the crystals 
  
in CD3NO2 afforded (31P-NMR) the previously observed two signals, with minimal variations due 
to the solvent change. This behavior showed the presence, in solution, of a rapid equilibrium 
involving [SP4-3]-4 and another species, which was identified as [SP4-2]-4 on the basis of 1H- and 
13C- NMR spectra carried out on the solution (Scheme 2). The portion of 1H-NMR spectrum where 
signals of DMSO residues were observed is reported in Figure 2. For each isomer, DMSO methyl 
groups are not equivalent (singlets a, a' for the main isomer and singlets b, b' for the other one). For 
signals a and b 3JH-Pt coupling constants of 25 and 18 Hz respectively could be measured. This 
feature, together with the chemical shifts observed (3.48 and 3.19 ppm), is typical of S-coordinated 
DMSO in platinum complexes [12c,13d,14]. On the other hand, signals a' and b' were observed at 
2.47 and 2.99 ppm as singlets, without any measurable H-Pt coupling constants, in agreement with 
data described for O-coordinated DMSO ligands [12c,13d,14]. An appreciable broadening was 
observed for signal b' (Figure 2). It seems reasonable to attribute this resonance to O-coordinated 
DMSO of [SP4-2]-4, due to the strong trans effect exerted by PPh3. 
 
BF4
[SP4-3]-4
BF4
[SP4-2]-4
 
Scheme 2. Equilibrium between [SP4-3]-4 and [SP4-2]-4 in CD3NO2 solution. 
 
The presence of a S-coordinated and an O-coordinated DMSO ligands in both isomers [SP4-3]-4 
and [SP4-2]-4 was confirmed by 13C-NMR spectrum in CD3NO2. Non-equivalent methyl groups of 
main isomer afforded signals at 47.5 and 38.2, while for the other complex signals at 44.4 and 37.1 
ppm were observed, in agreement with literature data [15] reporting high-field or low-field shifts 
with respect to free DMSO in case of O- or S-coordination respectively.  
  
 
Figure 2. 1H-NMR signals of methyl hydrogen atoms in [SP4-3]-4/[SP4-2]-4 mixture 
 
Complexes 1-4 were stable in DMSO solution, as checked by 31P-NMR spectroscopy. 
 
3.2 Structural determinations  
Selected bond lengths and angles for complexes 1-3 are reported in Table 2, while the views of 
molecular structures for the same cations are represented in Figure 3. In all cases, the coordination 
around platinum(II) is square planar, with small deviations from ideality.  
 
Table 2. Selected bond lenghts (Å) and angles (°) in the structures of 1-3. 
 1 2 3⋅ 0.5(CH3CN) 
Pt(1)−Cl(1) 2.2727(12) 2.2755(14) 2.3427(10) 
Pt(1)−P(1) 2.2542(12) 2.2556(12) 2.2481(10) 
Pt(1)−N(1) 2.054(4) 2.052(4) 2.015(3) 
Pt(1)−N(2) 2.087(4) 2.090(4) 2.029(4) 
P(1)−Pt(1)−Cl(1) 89.43(5) 90.66(5) 176.60(4) 
P(1)−Pt(1)−N(1) 98.33(13) 97.88(12) 93.42(10) 
P(1)−Pt(1)−N(2) 176.20(12) 177.23(12) 90.07(10) 
Cl(1)−Pt(1)−N(1) 172.04(13) 171.46(12) 88.12(10) 
Cl(1)−Pt(1)−N(2) 92.75(13) 91.26(13) 88.48(10) 
N(1)−Pt(1)−N(2) 79.60(18) 80.21(18) 176.16(14) 
 
 
  
 
Figure 3. View of the molecular structure of cations [Pt(PPh3)BipyCl]+ as found in the crystal of 1 (A), [Pt(PPh)3PhenCl]+ as found in the crystal of 2 
(B) and [Pt(PPh)3Py2Cl]+ as found in the crystal of 3 (C). 
 
Bond lengths and angles in complexes 1 and 2 are very similar between themselves, with Pt‒N(2) 
bond distance slightly longer than Pt‒N(1) one in both cases. This feature is probably related to the 
trans influence exerted by the PPh3 group and is in agreement with an analogous cationic complex 
bearing PPh3 and 1,10-phenanthroline-5,6-dione residues [16]. In the case of complex 2, pi‒pi 
stacking interactions between phenanthroline rings of contiguous molecules was observed, at 
variance with the aforementioned structure [16], where steric hindrance of bulky PPh3 seems to 
prevent this intermolecular interaction. In our case, planar phenanthroline or dipyridine ligands of 
two contiguous molecules are parallel and staggered (Figure 4), with the distance between the 
parallel plans only slightly higher than in graphite [17] (3.42 -3.54 Å vs. 3.35Å). 
In complex 3, Pt‒Cl bond distance is longer than in complexes 1 and 2, as expected, due to the 
presence of PPh3 residue in the trans position. 
  
 
Figure 4. Intermolecular stacking interactions in cis-[Pt(PPh3)(phen)Cl]+ 
The most significant geometric parameters for [SP4-3]-4 are reported in Table 3. The coordination 
around platinum(II) is square planar, with the two DMSO units in mutual trans position, one S- and 
the other O-coordinated. Chloride and O-DMSO ligands are disordered and, in the model, have 
been refined as distributed in two limit positions. In the view of the molecular structure of [SP4-3]-
4 (Figure 5), only the most populated limit positions have been represented. 
Table 3. Selected bond lenghts (Å) and angles (°) for [SP4-3]-4  
Pt(1)−Cl(1A) 2.322(8) Pt(1)−S(1) 2.2011(16) 
Pt(1)−P(1) 2.2684(15) Pt(1)−O(2A) 2.102(11) 
S(1)−Pt(1)−Cl(1A) 90.6(3) P(1)−Pt(1)−S(1) 92.32(6) 
O(2A)−Pt(1)−Cl(1A) 91.2(4) O(2A)−Pt(1)−S(1) 177.4(3) 
P(1)−Pt(1)−Cl(1A) 168.0(10) O(2A)−Pt(1)−P(1) 85.6(3) 
 
  
 
Figure 5. View of the molecular structure of cation [PtCl(PPh)3(DMSO)2]+ as found in the crystal of [SP4-3]-4. Chlorine and one dimethylsulfoxide 
ligand are disordered. Thermal ellipsoids are at 20% probability. 
 
Analogous ionic complexes of Ru(II) [18], Rh(III) [19], Pd(II) [20] and Pt(II) [13c] are described 
where at least two DMSO units are coordinated by sulphur and oxygen atoms. Our derivative can 
be compared with cis-[Pt(SOMe2)2(OSMe2)2][CF3SO3]2 [13c], where coordination around 
platinum(II) is again square planar with only slight deviations and O- and S-coordinated DMSO 
ligands are in mutual trans positions. As for bond lengths, a longer Pt‒O bond distance was 
observed in [SP4-3]-4 than in the aforementioned [13c] homoleptic compound (2.089 vs. a mean 
value of 2.045 Å), while S‒Pt bond is shorter (2.202 vs. 2.207 Å). Finally, S‒O bond distances in 
[SP4-3]-4 are shorter than in the other complex (1.430 vs. 1.453 Å for S-coordinated ligand and 
1.510 vs. 1.545 Å for the O-coordinated one). 
3.3 Inhibition growth assay 
The cytotoxic effect of the new complexes 1-4 was evaluated on three human tumor cell lines, 
MSTO-211H (human biphasic mesothelioma), HeLa (human cervix adenocarcinoma) and HepG2 
(human hepatocellular carcinoma). The results have been expressed as percentage of cell viability 
with respect to control cultures and have been reported in Table 4. 
 
Table 4. Cell viability in the presence of platinum complex 1-4 at 20 µM concentration. 
Complex 
Cell lines a,b (viability %) 
MSTO-211H HeLa HepG2 
1 63.81 90.15 81.42 
2 29.52 89.37 95.35 
  
3 70.48 97.30 95.35 
4 86.67 100 99.45 
a Values are the mean of three independent experiments. 
b Results are expressed as percentage of viability with respect to control cultures. 
 
All synthesized complexes exert a weak cytotoxicity on the cell lines taken into account, 
nevertheless, the MSTO-211H cells appear the most sensitive, showing the lower viability 
percentage values for all considered complexes, with respect to both HeLa and HepG2. In 
particular, on mesothelioma cells the cell viability decreases from 86.67% in the presence of 
complex 4 to 29.52% when incubated with complex 2. Interestingly, in this cell line the observed 
cytotoxic effect appears dependent on the increase in steric hindrance of the substituent or of the 
chelating group coordinating the metal. This behavior appears confirmed also for HeLa cells, while 
for HepG2, likely due to the very low antiproliferative effect, none relationship can be highlighted. 
 
4. Conclusions 
Ionic platinum complexes containing PPh3 can be conveniently prepared by dechlorination of cis-
[PtCl2(PPh3)(NCMe)] [5f] by a slight excess of AgBF4 at room temperature, followed by the 
suitable nucleophile. While the use of symmetric chelating bidentate ligands (bipy and phen) 
affords single products, with monodentate ligands mixtures of geometric (L = Py) and/or 
coordination (L = DMSO) isomers are observed in solution. In both cases studied, anyway, a single 
isomer was isolated and structurally characterized. The structure of DMSO complex [SP4-3]-
[PtCl(PPh3)(SOMe2)(OSMe2)]+ is particularly interesting for the presence of two DMSO residues 
bonded to platinum by sulphur and oxygen atoms and in mutual trans position. To the best of our 
knowledge there is only another example of this kind in the literature [13c]. The DMSO complex 
showed a dynamic behavior in solution, where 1H- and 31P-NMR spectroscopy allowed to observe 
the presence of an equilibrium between [SP4-3]- and [SP4-2]-4 isomers. The constant of the 
equilibrium (1), assessed by the integration of 1H-NMR signals of methyl groups, is about 0.4 
(CD3NO2, 25 °C). 
[SP4-3]-4  
K
 [SP4-2]-4       (1) 
 
The cytotoxic effect exerted by complexes 1-4 on MSTO-211H (human biphasic mesothelioma), 
HeLa (human cervix adenocarcinoma) and HepG2 (human hepatocellular carcinoma) cell lines was 
  
generally low. Anyway, the highest activity was exerted by phenanthroline complex 2 against the 
most sensitive MSTO-211H cell line. This result suggest that the presence of chelating, sterically 
hindered bidentate ligands could enhance the antiproliferative activity. 
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Dehalogenation of cis-[PtCl2(PPh3)(NCMe)], followed by ligand substitution afforded ionic 
complexes [PtCl(PPh3)(L˄L)][BF4] {L˄L = 2,2'-bipyridyl (1) 1,10-phenanthroline (2)} and 
[PtCl(PPh3)(L)2][BF4] {L = pyridine (3), dimethyl sulfoxide (4)}. The complexes were 
characterized by X-ray diffraction and spectroscopic techniques. Antiproliferative activity against 
MSTO-211H, HeLa and HepG2 tumor cell lines was evaluated in vitro. 
 
 
 
